Invention Grant
- Patent Title: Anti-hDlk-1 antibody having an antitumor activity in vivo
- Patent Title (中): 具有体内抗肿瘤活性的抗hDlk-1抗体
-
Application No.: US12404419Application Date: 2009-03-16
-
Publication No.: US08017118B2Publication Date: 2011-09-13
- Inventor: Koji Nakamura , Rie Tajima , Shankar Kumar , J. Yun Tso , Naoya Tsurushita
- Applicant: Koji Nakamura , Rie Tajima , Shankar Kumar , J. Yun Tso , Naoya Tsurushita
- Applicant Address: JP Nogawa, Miyamae, Kawasaki, Kanagawa
- Assignee: LivTech Inc. — Teikyo University Biotechnology Research Center
- Current Assignee: LivTech Inc. — Teikyo University Biotechnology Research Center
- Current Assignee Address: JP Nogawa, Miyamae, Kawasaki, Kanagawa
- Agency: McDermott Will & Emery LLP
- Main IPC: C07K16/18
- IPC: C07K16/18
Abstract:
The present invention provides antibodies specifically against hDlk-1 and having anti-tumor activity in vivo (anti-hDlk-1 antibodies), a fragments of the antibodies, hybridomas that produce the antibodies, a complex of the antibody or antibody fragment and an agent, a pharmaceutical composition comprising the antibody and the like, a tumor therapeutic agent, a tumor angiogenesis inhibitor, a tumor diagnostic agent, a method for detecting tumor, a kit for detecting and/or diagnosing tumor, etc.
Public/Granted literature
- US20090299038A1 ANTI-HDLK-1 ANTIBODY HAVING AN ANTITUMOR ACTIVITY IN VIVO Public/Granted day:2009-12-03
Information query
